Andrea DeCensi

13.5k total citations · 1 hit paper
246 papers, 9.2k citations indexed

About

Andrea DeCensi is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Andrea DeCensi has authored 246 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Oncology, 103 papers in Genetics and 77 papers in Molecular Biology. Recurrent topics in Andrea DeCensi's work include Estrogen and related hormone effects (96 papers), Cancer Risks and Factors (49 papers) and Retinoids in leukemia and cellular processes (47 papers). Andrea DeCensi is often cited by papers focused on Estrogen and related hormone effects (96 papers), Cancer Risks and Factors (49 papers) and Retinoids in leukemia and cellular processes (47 papers). Andrea DeCensi collaborates with scholars based in Italy, United Kingdom and United States. Andrea DeCensi's co-authors include Bernardo Bonanni, Matteo Puntoni, Sara Gandini, Massimiliano Cazzaniga, Aliana Guerrieri‐Gonzaga, Alessandra Gennari, Leslie G. Ford, Harriet Johansson, Davide Serrano and Umberto Veronesi and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Andrea DeCensi

238 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

2010 713 citations Andrea DeCensi, Matteo Puntoni et al. Cancer Prevention Research profile →

Peers

Andrea DeCensi

ONCOL

GENET

PRM

Powel H. Brown United States

Bernardo Bonanni Italy

R. Daniel Beauchamp United States

Stimson P. Schantz United States

Francesco Boccardo Italy

Zhi‐Ming Shao China

Mia M. Gaudet United States

Paul E. Goss United States

Daniel D. Karp United States

Bernard Têtu Canada

Powel H. Brown United States

Andrea DeCensi

5.2k ×1.3

3.9k ×1.1

ONCOL

2.3k ×0.8

GENET

2.6k ×1.1

1.3k ×1.0

PRM

Citations per year, relative to Andrea DeCensi Andrea DeCensi (= 1×) peers Powel H. Brown

Countries citing papers authored by Andrea DeCensi

Since Specialization

Citations

This map shows the geographic impact of Andrea DeCensi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea DeCensi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea DeCensi more than expected).

Fields of papers citing papers by Andrea DeCensi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea DeCensi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea DeCensi. The network helps show where Andrea DeCensi may publish in the future.

Co-authorship network of co-authors of Andrea DeCensi

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea DeCensi. A scholar is included among the top collaborators of Andrea DeCensi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea DeCensi. Andrea DeCensi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carbone, Alessio, Martino Oliva, Matteo Puntoni, et al.. (2025). Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer. JNCI Journal of the National Cancer Institute.

Thorat, Mangesh A., Marc Arbyn, David Baldwin, et al.. (2025). European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer. Molecular Oncology. 20(1). 117–133. 1 indexed citations

Piccardo, Arnoldo, Gianluca Bottoni, Michela Massollo, et al.. (2024). Role of⁶⁴CuCl₂PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and¹⁸F-FDG PET/CT. Journal of Nuclear Medicine. 65(9). 1357–1363. 3 indexed citations

Webber, Tania Buttiron, et al.. (2023). Taste and Smell Disorders in Cancer Treatment: Results from an Integrative Rapid Systematic Review. International Journal of Molecular Sciences. 24(3). 2538–2538. 22 indexed citations

Massollo, Michela, Francesco Fiz, Gianluca Bottoni, et al.. (2021). To Enhance or Not to Enhance? The Role of Contrast Medium 18F-FDG PET/CT in Recurrent Ovarian Carcinomas. Medicina. 57(6). 561–561. 3 indexed citations

Grosso, Federica, Lorenzo D’Ambrosio, Massimo Zucchetti, et al.. (2020). Pharmacokinetics, safety, and activity of trabectedin as first‐line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group. Cancer. 126(21). 4726–4734. 20 indexed citations

Lazzeroni, Matteo, Andrea DeCensi, Aliana Guerrieri‐Gonzaga, et al.. (2020). Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast. Modern Pathology. 33(6). 1065–1077. 5 indexed citations

Visvanathan, Kala, Carol J. Fabian, Elissa Bantug, et al.. (2019). Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology. 37(33). 3152–3165. 117 indexed citations

Oza, Amit M., Frédèric Selle, Ірина Давиденко, et al.. (2016). Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study. International Journal of Gynecological Cancer. 27(1). 50–58. 55 indexed citations

10.

DeCensi, Andrea, Matteo Puntoni, Aliana Guerrieri‐Gonzaga, et al.. (2015). Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial. Cancer Prevention Research. 8(10). 888–894. 27 indexed citations

11.

Gandini, Sara, Matteo Puntoni, Brandy M. Heckman‐Stoddard, et al.. (2014). Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders. Cancer Prevention Research. 7(9). 867–885. 340 indexed citations

12.

Gandini, Sara, Aliana Guerrieri‐Gonzaga, Giancarlo Pruneri, et al.. (2013). Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials. Annals of Oncology. 25(3). 618–623. 29 indexed citations

13.

Bonanni, Bernardo, Matteo Puntoni, Massimiliano Cazzaniga, et al.. (2012). Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial. Journal of Clinical Oncology. 30(21). 2593–2600. 195 indexed citations

14.

Puntoni, Matteo, Alessandra Argusti, C. Crosta, et al.. (2012). A Randomized, Placebo-Controlled, Preoperative Trial of Allopurinol in Subjects with Colorectal Adenoma. Cancer Prevention Research. 6(2). 74–81. 14 indexed citations

15.

Maisonneuve, Patrick, Vincenzo Bagnardi, Massimo Bellomi, et al.. (2011). Lung Cancer Risk Prediction to Select Smokers for Screening CT—a Model Based on the Italian COSMOS Trial. Cancer Prevention Research. 4(11). 1778–1789. 89 indexed citations

16.

DeCensi, Andrea, Matteo Puntoni, Giancarlo Pruneri, et al.. (2011). Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial. Cancer Prevention Research. 4(8). 1181–1189. 48 indexed citations

17.

DeCensi, Andrea, Matteo Puntoni, Pamela J. Goodwin, et al.. (2010). Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis. Cancer Prevention Research. 3(11). 1451–1461. 713 indexed citations breakdown →

18.

DeCensi, Andrea, Aliana Guerrieri‐Gonzaga, Sara Gandini, et al.. (2010). Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Annals of Oncology. 22(3). 582–587. 59 indexed citations

19.

Johansson, Harriet, Massimiliano Cazzaniga, Bernardo Bonanni, et al.. (2006). Effects of low dose tamoxifen on circulating levels of hormones, C-telopeptide and HER2 extracellular domain in women with primary breast cancer. Cancer Research. 66. 753–753. 2 indexed citations

20.

Costa, A., Franca Formelli, F. Chiesa, et al.. (1994). Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide.. PubMed. 54(7 Suppl). 2032s–2037s. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact